Generate a tailored SOP for Dr. Charles Rudin. Improve your application with a focused, well-structured draft.
Charles M. Rudin is a physician-scientist and the Chief of the Thoracic Oncology Service at Memorial Sloan Kettering Cancer Center. His research focuses on the development and testing of novel therapeutic approaches for lung cancer, utilizing preclinical models and patient-derived xenografts. Dr. Rudin emphasizes the integration of his studies with early-phase clinical trials, aiming to enhance treatment methodologies for lung cancer. His lab is committed to exploring innovative techniques for complex cancer treatment scenarios, particularly those involving drug resistance and the cellular mechanisms that allow lung cancer cells to evade targeted therapies.
Memorial Sloan Kettering Cancer Center • New York, NY
Leads research in the Thoracic Oncology Service, focusing on lung cancer treatment and novel therapeutic strategies.
Administered through the Gerstner Sloan Kettering (GSK) Graduate School. The program focus is Cancer Biology and includes faculty from the Department of Molecular Pharmacology.